Mizuho raised the firm’s price target on Abbott to $130 from $115 and keeps a Neutral rating on the shares post the Q3 report. Despite the company’s momentum, Mizuho continues to look for sustainable operating margin expansion post the Testing sunset, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
Questions or Comments about the article? Write to editor@tipranks.com